A detailed history of Ing Groep Nv transactions in Amgen Inc stock. As of the latest transaction made, Ing Groep Nv holds 303,923 shares of AMGN stock, worth $96 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
303,923
Previous 256,752 18.37%
Holding current value
$96 Million
Previous $73 Million 30.08%
% of portfolio
0.58%
Previous 0.51%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $12.4 Million - $15.1 Million
47,171 Added 18.37%
303,923 $95 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $8.56 Million - $10.3 Million
-31,830 Reduced 11.03%
256,752 $73 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $40.9 Million - $46.1 Million
159,782 Added 124.05%
288,582 $83.1 Million
Q3 2023

Oct 27, 2023

BUY
$218.65 - $271.46 $1.88 Million - $2.34 Million
8,620 Added 7.17%
128,800 $34.6 Million
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $1.66 Million - $1.96 Million
-7,744 Reduced 6.05%
120,180 $26.7 Million
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $16.3 Million - $19.8 Million
72,062 Added 129.0%
127,924 $30.9 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $1.04 Million - $1.32 Million
4,533 Added 8.83%
55,862 $14.7 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $10.1 Million - $11.4 Million
44,836 Added 690.53%
51,329 $11.6 Million
Q2 2022

Aug 08, 2022

BUY
$230.71 - $256.74 $1.5 Million - $1.67 Million
6,493 New
6,493 $1.58 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $37.8 Million - $41.8 Million
-172,201 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $15.6 Million - $17.8 Million
78,239 Added 83.27%
172,201 $38.7 Million
Q3 2021

Nov 02, 2021

BUY
$212.27 - $248.7 $11.2 Million - $13.1 Million
52,760 Added 128.05%
93,962 $20 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $4.71 Million - $5.23 Million
-20,165 Reduced 32.86%
41,202 $10 Million
Q1 2021

May 12, 2021

SELL
$221.91 - $258.6 $61,469 - $71,632
-277 Reduced 0.45%
61,367 $15.3 Million
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $5.55 Million - $6.61 Million
25,653 Added 71.28%
61,644 $14.2 Million
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $7.28 Million - $8.09 Million
31,014 Added 623.15%
35,991 $9.15 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $984,500 - $1.21 Million
4,977 New
4,977 $1.17 Million
Q1 2020

May 06, 2020

SELL
$182.24 - $241.7 $7.45 Million - $9.89 Million
-40,905 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $27 Million - $34.7 Million
-142,520 Reduced 77.7%
40,905 $9.86 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $6.39 Million - $7.66 Million
36,725 Added 25.03%
183,425 $35.5 Million
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $2.41 Million - $2.82 Million
14,439 Added 10.92%
146,700 $27 Million
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $6.27 Million - $7.07 Million
-34,672 Reduced 20.77%
132,261 $25.1 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $98,476 - $114,954
-552 Reduced 0.33%
166,933 $32.5 Million
Q3 2018

Nov 06, 2018

BUY
$185.29 - $208.89 $12.6 Million - $14.2 Million
67,974 Added 68.31%
167,485 $34.7 Million
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $16.5 Million - $18.6 Million
99,511 New
99,511 $18.4 Million
Q1 2018

May 07, 2018

SELL
$169.43 - $198.0 $28.5 Million - $33.3 Million
-168,273 Closed
0 $0
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $3.43 Million - $3.83 Million
-20,327 Reduced 10.78%
168,273 $29.3 Million
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $31.6 Million - $36 Million
188,600
188,600 $35.2 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.